Abstract

Fatigue is the most prevalent symptom in breast cancer. It might be perceived differently among patients over time as a consequence of the differing patients’ adaptation and psychological adjustment to their cancer experience which can be related to response shift (RS). RS analyses can provide important insights on patients’ adaptation to cancer but it is usually assumed that RS occurs in the same way in all individuals which is unrealistic. This study aimed to identify patients’ subgroups in which different RS effects on self‐reported fatigue could occur over time using a combination of methods for manifest and latent variables. The FATSEIN study comprised 466 breast cancer patients followed over a 2‐year period. Fatigue was measured with the Multidimensional Fatigue Inventory questionnaire (MFI‐20) during 10 visits. A novel combination of Mixed Models, Growth Mixture Modeling, and Structural Equation Modeling was used to assess the occurrence of RS in fatigue changes to identify subgroups displaying different RS patterns over time. An increase in fatigue was evidenced over the 8‐month follow‐up, followed by a decrease between the 8‐ and 24‐month. Four latent classes of patients were identified. Different RS patterns were detected in all latent classes between the inclusion and 8 months (last cycle of chemotherapy). No RS was evidenced between 8‐ and 24‐month. Several RS effects were evidenced in different groups of patients. Women seemed to adapt differently to their treatment and breast cancer experience possibly indicating differing needs for medical/psychological support.

Highlights

  • Cancer-­related fatigue is one of the most prevalent symptom [1] in breast cancer patients

  • The variables significantly associated with fatigue change were time, chemotherapy and marital status

  • LC1 corresponds to the oldest patients receiving less chemotherapy and showing the lowest increase in latent fatigue and the highest response shift (RS) effects

Read more

Summary

Introduction

Cancer-­related fatigue is one of the most prevalent symptom [1] in breast cancer patients. Several studies have explored fatigue change in breast cancer patients during treatments using the MFI-­20 [4,5,6]. These studies showed heterogeneous results with different patterns of increase, decrease, or stability in fatigue over time. All these studies assumed so-­called longitudinal measurement invariance [7] assuming that patients respond consistently on patient-­ reported outcomes (PRO) and that they are directly comparable over time, which can be questioned. In breast cancer, it is likely that patients might regularly adapt to their illness and, as a consequence, might give different answers to the questionnaires over time, because their fatigue has changed, and because

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call